# Atrial Fibrillation Algorithms Clinical Validation Study

Study · id `cardio:ct-nct04699812` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04699812](<https://clinicaltrials.gov/study/NCT04699812>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04699812

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 573 participants.

## Technical summary

Registry record NCT04699812. Non-randomized; no masking; primary purpose screening. Start 2020-11-16 (actual); primary completion 2021-04-19 (actual). Results posted on 2022-08-24.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 573 participants (enrolled count; ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Started: 2020-11-16 (actual) (ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Primary completion: 2021-04-19 (actual) (ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Completion: 2021-12-17 (actual) (ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Results first posted: 2022-08-24 (ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04699812, source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04699812-2022-08-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Atrial Fibrillation Algorithms Clinical Validation Study
- Condition: Atrial Fibrillation
- Intervention (Device): ELECTROCARDIOGRAM (ECG) PATCH WEAR
- Lead sponsor: Apple Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: IQVIA Pty Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Apple (`cardio:apple`)
- Registry lists this organization as a collaborator: IQVIA Pty Ltd (`cardio:org-iqvia-pty-ltd`)

## Provenance

Content hash: 1c91794103ffe69f099cef6cc401275c99a36c769d14dabc51fe5b57f92fdb30
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
